Understanding the mechanisms of APRIL action in colorectal cancer may lead to new diagnostic and therapy options, as well as offer understanding on the intricate connections between the immune system and colorectal malignancies [2,3,4,5]. The gene discussed is TNFSF13; the disease is colorectal cancer.